ACCO Brands Corporation
NYSE:ACCOBusiness Equipment & Supplies
+$0.05 today
- Market cap
- $517.11M
- Beta
- 1.21
- P/E (TTM)
- 4.9
- EPS (TTM)
- $0.80
- Dividend yield
- 7.70%
Volume 1.77M
Average 1.07M
ACCO Other Non-current Assets
Long-term assets not reported separately.
ACCO Brands CorporationNYSE: ACCO
Other Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Other non-current assets remains negative
Q1 FY2026 other non-current assets was -$389.3M, compared with -$338.3M a year earlier.
Context
- Other non-current assets amounted to 17.1% of total assets at the end of Q1 FY2026, up 2.1 pp from a year earlier.
- Other non-current assets increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether other non-current assets keeps falling in the next quarterly balance sheet after a -15.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- (371.9M) USD
- Year-over-year change
- -1643.2%
| Period | Period end | Other Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (371.9M) | -1643.2% |
| FY2024 | 2024-12-31 | 24.1M | +63.9% |
| FY2023 | 2023-12-31 | 14.7M | -4.5% |
| FY2022 | 2022-12-31 | 15.4M | -2.5% |
| FY2021 | 2021-12-31 | 15.8M | — |
Other Non-current Assets vs competitors
How ACCO compares with its peers on the latest reported figures
- ACCO's Mar 2026 other non-current assets of -$389.3M is the lowest of the 11 companies compared; the peer median is $58.23M.
- Its year-over-year change of -15.1% is the 9th highest of 11, against a peer median of +12.0%.
- Other non-current assets amounts to 17.1% of total assets for ACCO, versus a peer median of 9.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $977.43M | +78345.7% | -51.6% | 534.5% | |
| Mar 2026 | $209.6M | +68.6% | +20.8% | 14.6% | |
| Mar 2026 | $155.2M | +12.3% | +44.1% | 12.6% | |
| Mar 2026 | $105.7M | +19.6% | +52.8% | 5.7% | |
SBCSBC Medical Group Holdings Incorporated | Mar 2026 | $61.75M | +156.5% | -53.0% | 15.9% |
| Mar 2026 | $54.7M | +5.8% | +26.7% | 13.9% | |
| Apr 2026 | $12.46M | -9.2% | +52.5% | 1.4% | |
| Feb 2026 | $6.88M | +11.7% | — | 1.9% | |
| Mar 2026 | $2.92M | -16.3% | +9.2% | 0.9% | |
| Mar 2026 | $0 | -100.0% | — | 0.0% | |
| Mar 2026 | -$389.3M | -15.1% | — | 17.1% | |
| Peer median (excluding ACCO) | $58.23M | +12.0% | +23.7% | 9.2% | |
Competitors are the stored peer set for ACCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 41.2M | 62.2M | 66.4M | 74.1M | 64.4M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 416.1M | 384.1M | 430.7M | 348.9M | 359.7M |
| Inventory | 428M | 395.2M | 327.5M | 270.4M | 289.1M |
| Other Current Assets | 39.6M | 40.8M | 30.8M | 38.1M | 37.1M |
| Total Current Assets | 924.9M | 882.3M | 855.4M | 731.5M | 750.3M |
| Property, Plant & Equipment (Net) | 319.8M | 273.9M | 261.1M | 218.5M | 606.4M |
| Goodwill | 802.5M | 671.5M | 590M | 446.4M | 478.5M |
| Intangible Assets | 902.2M | 847M | 815.7M | 709.6M | 696.9M |
| Long-term Investments | 10.2M | 4.9M | 3.2M | 9M | 0 |
| Tax Assets | 115.9M | 99.7M | 104.7M | 89.3M | 92.8M |
| Other Non-current Assets | 15.8M | 15.4M | 14.7M | 24.1M | (371.9M) |
| Total Non-current Assets | 2.17B | 1.91B | 1.79B | 1.5B | 1.5B |
| Total Assets | 3.09B | 2.79B | 2.64B | 2.23B | 2.25B |
| Account Payables | 308.2M | 239.5M | 183.7M | 167.3M | 186.7M |
| Short-term Debt | 67.4M | 81.2M | 36.7M | 51.3M | 30.8M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 157.3M | 0 | 0 |
| Other Current Liabilities | 276.1M | 230M | (21.3M) | 120.9M | 150.2M |
| Total Current Liabilities | 708.6M | 589M | 542M | 490.3M | 465.3M |
| Long-term Debt | 954.1M | 936.5M | 882.2M | 783.3M | 806M |
| Deferred Tax Liabilities | 145.2M | 144.1M | 125.6M | 111.9M | 108.8M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 329.6M | 239.8M | 231.2M | 169.9M | 144.8M |
| Total Non-current Liabilities | 1.52B | 1.4B | 1.32B | 1.13B | 1.12B |
| Total Liabilities | 2.23B | 1.98B | 1.86B | 1.62B | 1.59B |
| Common Stock | 1M | 1M | 1M | 1M | 1M |
| Retained Earnings | (462M) | (504.4M) | (556M) | (687.6M) | (675.3M) |
| Accumulated OCI | (535.5M) | (540.3M) | (526.3M) | (572.1M) | (522.6M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 864.8M | 810.1M | 787M | 606.1M | 664.6M |
| Total Debt | 1.11B | 1.09B | 1.02B | 923M | 920.8M |
| Net Debt | 1.07B | 1.03B | 949.8M | 848.9M | 856.4M |
ACCO Brands Corporation
NYSE:ACCO
Intrinsic Alpha fair value
Locked
Current Price
$5.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.